193 related articles for article (PubMed ID: 35962191)
1. Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC).
Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Cell Mol Immunol; 2022 Sep; 19(9):1054-1066. PubMed ID: 35962191
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Drug Resist Updat; 2024 Mar; 73():101055. PubMed ID: 38387281
[TBL] [Abstract][Full Text] [Related]
3. The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.
Chen J; Zhang W; Wang Y; Zhao D; Wu M; Fan J; Li J; Gong Y; Dan N; Yang D; Liu R; Zhan Q
Oncogene; 2019 Apr; 38(14):2533-2550. PubMed ID: 30532074
[TBL] [Abstract][Full Text] [Related]
4. Co-targeting FAK and Gli1 inhibits the tumor-associated macrophages-released CCL22-mediated esophageal squamous cell carcinoma malignancy.
Chen J; Zhu Y; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
MedComm (2020); 2023 Dec; 4(6):e381. PubMed ID: 37846367
[TBL] [Abstract][Full Text] [Related]
5. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
6. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling.
Zhang J; Gelman IH; Katsuta E; Liang Y; Wang X; Li J; Qu J; Yan L; Takabe K; Hochwald SN
Cell Mol Gastroenterol Hepatol; 2019; 8(1):37-60. PubMed ID: 30836148
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.
Sun Y; Qian Y; Chen C; Wang H; Zhou X; Zhai W; Qiu L; Zhou X; Ning H; Zhao Y; Shi C; Han L; Qi Y; Wu Y; Gao Y
J Exp Clin Cancer Res; 2022 Apr; 41(1):145. PubMed ID: 35428295
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
[TBL] [Abstract][Full Text] [Related]
9. Chrysin serves as a novel inhibitor of DGK
Chen J; Wang Y; Zhao D; Zhang L; Zhang W; Fan J; Li J; Zhan Q
Acta Pharm Sin B; 2021 Jan; 11(1):143-155. PubMed ID: 33532186
[TBL] [Abstract][Full Text] [Related]
10. AKT2
Chen J; Zhang L; Zhu Y; Zhao D; Zhang J; Zhu Y; Pang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Signal Transduct Target Ther; 2024 Jan; 9(1):21. PubMed ID: 38280862
[TBL] [Abstract][Full Text] [Related]
11. RSK4 promotes the macrophage recruitment and M2 polarization in esophageal squamous cell carcinoma.
He S; Lu M; Zhang L; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166996. PubMed ID: 38142759
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.
Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A
Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457
[TBL] [Abstract][Full Text] [Related]
13. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
[TBL] [Abstract][Full Text] [Related]
14. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis.
Li M; Wang L; Zhan Y; Zeng T; Zhang X; Guan XY; Li Y
Am J Pathol; 2019 Jul; 189(7):1462-1472. PubMed ID: 31054987
[TBL] [Abstract][Full Text] [Related]
15. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
16. Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4/STAT6 in the tumor microenvironment.
Kimura S; Noguchi H; Nanbu U; Nakayama T
Oncol Lett; 2021 May; 21(5):383. PubMed ID: 33777206
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
18. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
[TBL] [Abstract][Full Text] [Related]
19. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
